Table 1.
Clinical features | Skull base bone destruction
|
P-value | |
---|---|---|---|
Without | With | ||
Age, years | 0.843 | ||
<46 | 142 | 77 | |
≥46 | 152 | 78 | |
Sex | 0.239 | ||
Male | 208 | 101 | |
Female | 86 | 54 | |
Pathology | 0.725 | ||
Undifferentiated NKC | 267 | 143 | |
Differentiated NKC | 27 | 12 | |
Clinical stages | <0.001 | ||
I | 23 | 0 | |
II | 113 | 0 | |
III | 118 | 54 | |
IV | 40 | 101 | |
T-staging | <0.001 | ||
T1 | 57 | 0 | |
T2 | 149 | 0 | |
T3 | 74 | 58 | |
T4 | 14 | 97 | |
N-staging | 0.340 | ||
N0 | 91 | 51 | |
N1 | 105 | 53 | |
N2 | 72 | 44 | |
N3 | 26 | 7 | |
Chemotherapy | <0.001 | ||
No | 197 | 55 | |
Yes | 97 | 100 | |
Distant bone metastases | 0.036 | ||
No | 280 | 143 | |
Yes | 14 | 12 |
Abbreviations: NKC, nonkeratinizing carcinoma; NPC, nasopharyngeal carcinoma.